Loading clinical trials...
Loading clinical trials...
Measurement of in Vivo Mitochondrial Capacity in Infants: a 31P-MRS Pilot Study
The overarching aim of this project is to determine the test re-test reliability of 31P-magnetic resonance spectroscopy measurements in infants. Primary endpoints include two separate measures of in vivo mitochondrial capacity (ATPmax) over a 1-10 day period to assess feasibility and reliability.
Age
0 - 0 years
Sex
ALL
Healthy Volunteers
Yes
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States
Start Date
May 21, 2019
Primary Completion Date
July 2, 2019
Completion Date
July 2, 2019
Last Updated
February 3, 2026
2
ACTUAL participants
Lead Sponsor
Pennington Biomedical Research Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions